Printer Friendly

COMPANY INFORMATION
YM BioSciences Inc. Building 11, 400-5045 Orbitor Dr Mississauga, ON L4W 4Y4 Tel: (905) 629-9761 Fax: (905) 629-4959 Contact Name Carolyn McEwen Industry Pharmaceuticals		Key Executives David G. P. Allan, CEO Leonard Vernon, CFO Develops and commercializes drugs primarily for the treatment of cancer.
FP ADVISOR COVERAGE YM BioSciences Inc. • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 936,111 Patheon Inc. 765,812 Cangene Corporation 238,751 Paladin Labs Inc. 109,693 Cardiome Pharma Corp. 54,672 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF JULY 29/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/YM AMEX/YMI $1.44 $2.42 on Aug. 27/09 $0.63 on Aug. 6/09 n.a. n.a. n.a. 0.73 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap (000s) 34,579 n.a. $ -0.26 Mar. 31/10 105.71% -6.11% -17.42% $115,532
ANNUAL FINANCIALS Periods ended: 12m June 30/09 12m June 30/08 12m June 30/07 $000s $000s $000s Operating revenue 4,543 4,859 4,408 Net income (13,069) (14,886) (31,730) Total assets 46,070 63,073 81,740 $ $ $ Earnings per share* (0.23) (0.27) (0.57) % % % Return on equity (28.50) (25.48) (39.77)   * Common
TRAILING 12-MONTH VALUES Periods ended: Mar. 31/10 Mar. 31/09 $000s $000s Operating revenue 2,837 5,243 Net income (15,634) (12,769) $ $ Earnings per share (0.27) (0.23)

COMPANY NEWS

Results for 'YM BioSciences Inc.' from past 30 days: No hits. (Links are to articles.)